Anatomy Atlas, USMLE, Clinical

ืจื›ื™ืฉื•ืช ืžืชื•ืš ื”ืืคืœื™ืงืฆื™ื”
3.2
38 ื‘ื™ืงื•ืจื•ืช
+10Kโ€
ื”ื•ืจื“ื•ืช
ืกื™ื•ื•ื’ ืชื•ื›ืŸ
ื›ื•ืœื
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš

ืžื™ื“ืข ืขืœ ื”ืืคืœื™ืงืฆื™ื” ื”ื–ื•

ืžืฉืื‘ื™ื ื‘ื—ื™ื ื:
* SkyscapeRX - ืžื“ืจื™ืš ืœืชืจื•ืคื•ืช ืœืจื•ืคืื™ื
* ืกืคืจ ืฉื—ื•ืจ ืฉื—ื•ืจ ืขืœ ื˜ื™ืคื•ืœ ืจืืฉื•ื ื™
* ืžื—ืฉื‘ื•ืŸ ืงืœื™ื ื™ ืฉืœ ืกืงื™ื™ืกืงื™ื™ืค ืคืœื•ืก
* ICD 10-CM

ื›ื•ืœืœ ืชื•ื›ืŸ ืœื“ื•ื’ืžื ืขื‘ื•ืจ ื”ืžืฉืื‘ื™ื ื”ื‘ืื™ื ** ืจื›ื™ืฉื” ื‘ืืคืœื™ืงืฆื™ื” ื”ื ื“ืจืฉืช ืœืฆืคื™ื™ื” ื‘ืชื•ื›ืŸ ืžืœื **:

* ืื˜ืœืก ื”ืื ื˜ื•ืžื™ื” ืฉืœ ื ื˜ืจ, ื’ืจืกื” ื“ื™ื’ื™ื˜ืœื™ืช ืื™ื ื˜ืจืืงื˜ื™ื‘ื™ืช ืฉืœ ื”ืžื”ื“ื•ืจื” ื”ืฉื‘ื™ืขื™ืช
- ืชืžื•ื ื•ืช ื‘ืจื–ื•ืœื•ืฆื™ื” ื’ื‘ื•ื”ื” ืขื ืงืžืฆื•ืฅ ื–ื•ื
- ื”ืคืขืœ / ื›ื‘ื” ืืช ื”ืชื•ื•ื™ื•ืช

ืื˜ืœืก ื”ืื ื˜ื•ืžื™ื” ื”ื™ื—ื™ื“ ืฉืžืื•ื™ืจ ืขืœ ื™ื“ื™ ืจื•ืคืื™ื, ืื˜ืœืก ื”ืื ื˜ื•ืžื™ื” ื”ืื ื•ืฉื™ืช, ื”ืžื”ื“ื•ืจื” ื”ืฉื‘ื™ืขื™ืช, ืžื‘ื™ื ืœืš ื”ืฉืงืคื•ืช ื‘ืขืœื•ืช ืฉื ืขื•ืœืžื™ ื•ื‘ืจื•ืจ ืœื”ืคืœื™ื ืฉืœ ื’ื•ืฃ ื”ืื“ื ืขื ื ืงื•ื“ืช ืžื‘ื˜ ืงืœื™ื ื™ืช. ื‘ื ื•ืกืฃ ืœื™ืฆื™ืจืชื• ื”ืžืคื•ืจืกืžืช ืฉืœ ื“"ืจ ืคืจื ืง ื ื˜ืจ, ืชื•ื›ืœื• ืœืžืฆื•ื ื›ืžืขื˜ 100 ืฆื™ื•ืจื™ื ืฉืœ ื“"ืจ ืงืจืœื•ืก ื. ืžื—ืื“ื•, ืื—ื“ ื”ืžืื™ื™ืจื™ื ื”ืจืคื•ืื™ื™ื ื”ืžื•ื‘ื™ืœื™ื ื‘ื™ืžื™ื ื•. ื™ื—ื“, ืฉื ื™ ืจื•ืคืื™ื-ืืžื ื™ื ืžื•ื›ืฉืจื™ื ื•ื™ื™ื—ื•ื“ื™ื™ื ืืœื” ืžื“ื’ื™ืฉื™ื ืืช ื”ื“ืขื•ืช ื”ืจืœื•ื•ื ื˜ื™ื•ืช ื‘ื™ื•ืชืจ ืžื‘ื—ื™ื ื” ืงืœื™ื ื™ืช ืฉืœ ื’ื•ืฃ ื”ืื“ื. ื‘ื ื•ืกืฃ, ืœืžืขืœื” ืž- 50 ืชืžื•ื ื•ืช ืจื“ื™ื•ืœื•ื’ื™ื•ืช ืฉื ื‘ื—ืจื• ื‘ืงืคื™ื“ื” ืขื•ื–ืจื•ืช ืœื’ืฉืจ ื‘ื™ืŸ ืื ื˜ื•ืžื™ื” ืœืื ื˜ื•ืžื™ื” ื—ื™ื” ื›ืคื™ ืฉื ื™ืชืŸ ืœืจืื•ืช ื‘ืชืจื’ื•ืœ ื™ื•ืžื™ื•ืžื™.

* ื”ื™ื•ืขืฅ ื”ืงืœื™ื ื™ ืฉืœ ืคืจื™
* ืžื“ืจื™ืš ืœืจืคื•ืื” ืฉืœ ื”ืจื™ืกื•ืŸ
* ื”ืžื“ืจื™ืš ืœื˜ื™ืคื•ืœ ืจืคื•ืื™ ื‘ื•ื•ืฉื™ื ื’ื˜ื•ืŸ
* ืžืงืจื™ ืขื–ืจื” ืจืืฉื•ื ื” ืขื‘ื•ืจ USMLE ืฉืœื‘ 2 CK
* ืฉืืœื•ืช ื•ืชืฉื•ื‘ื•ืช ืขื–ืจื” ืจืืฉื•ื ื” ืขื‘ื•ืจ USMLE ืฉืœื‘ 1
ืฉืืœื•ืช ื•ืชืฉื•ื‘ื•ืช ืขื–ืจื” ืจืืฉื•ื ื” ืขื‘ื•ืจ USMLE ืฉืœื‘ 2 CK
* ืกืคืจ ื™ื“ ืฉืœ ื”ืจื™ื™ื˜ ืœื™ื™ืŸ: ืžื“ืจื™ืš ืœืงืฆื™ื ื™ ื‘ืชื™ ื™ืœื“ื™ื
* ืžืขื‘ื“ื•ืช ืกืงื™ื™ืกืงื™ื™ืค - ื ื›ืชื‘ื• ืขืœ ื™ื“ื™ ืงืœื™ื ืื™ืช ืœืžื˜ืคืœื™ื
* ื›ืœื™ ืื‘ื—ื•ืŸ ื“ื™ืคืจื ืฆื™ืืœื™ ืฉืœ MobileDDx
* ืžื™ืœื•ืŸ ื”ืจืคื•ืื” ืฉืœ ืกื˜ื“ืžืŸ
* ื ื™ืชื•ื— ื‘ื”ื–ืžื ื” - ื™ื™ืขื•ืฅ ื˜ื™ืคื•ืœ ื‘ืžืงื•ื ื‘ื‘ืขื™ื•ืช 75+
* ืจืคื•ืืช ื—ื™ืจื•ื ื‘ื›ื•ื ื ื•ืช - ื’ื™ืฉื” ืžื•ื›ื•ื•ื ืช ืœื‘ืขื™ื•ืช ืชืจื’ื•ืœ ืจืคื•ืื™ EMERG
* ืจืคื•ืื” ืคื ื™ืžื™ืช ื‘ืฉื™ื—ื” - ื‘ื“ื™ืงื•ืช ืื‘ื—ื ื” ืื—ืจื•ื ื•ืช ื•ืืคืฉืจื•ื™ื•ืช ื˜ื™ืคื•ืœ
* ื™ืœื“ื™ื ื‘ืจืคื•ืื” - ื‘ื“ื™ืงื•ืช ืžืขื‘ื“ื”, ื ื”ืœื™ื ืœืฆื“ ื”ืžื™ื˜ื”, ื ื•ื–ืœื™ื ื•ืืœืงื˜ืจื•ืœื™ื˜ ื•ืขื•ื“
* ืžื™ืœื•ืŸ ืจืคื•ืื™ ืœืื ื’ืœื™ืช ืกืคืจื“ื™ืช-ืื ื’ืœื™ืช
* ืžื“ืจื™ืš ื’'ื•ื ืก ื”ื•ืคืงื™ื ืก ืœื’ื™ื ืงื•ืœื•ื’ื™ื” ื•ืžื™ื™ืœื“ื•ืช
* ืื‘ื—ื•ืŸ ื•ื˜ื™ืคื•ืœ ืฉื•ื˜ืฃ ืขื›ืฉื•ื•ื™ื™ื
* ื”ื ื—ื™ื•ืช ืขื™ืกื•ืง ืฉื•ื˜ืคื•ืช ื‘ื˜ื™ืคื•ืœ ืจืืฉื•ื ื™
* ืกื“ืจืช ืกืงื™ืจืช ืœื•ื—ื•ืช - ืคืชื•ืœื•ื’ื™ื”




ืชื›ื•ื ื•ืช ื™ื™ื—ื•ื“ื™ื•ืช ืœื—ื™ืกื›ื•ืŸ ื‘ื–ืžืŸ ืฉืœ ื”ืืคืœื™ืงืฆื™ื”:
- ื—ืคืฉ ืžื™ืœื•ืช ืžืคืชื— ื‘ื›ืœ ื”ืžืฉืื‘ื™ื ืžืžืกืš ื”ื‘ื™ืช
- ื”ื™ืกื˜ื•ืจื™ื” ืขื•ืงื‘ืช ืื—ืจ ื ื•ืฉืื™ื ืฉื ืฆืคื• ืœืื—ืจื•ื ื”
- ื”ื•ืกืฃ ืกื™ืžื ื™ื•ืช ืœืขื™ืชื™ื ืงืจื•ื‘ื•ืช ืœื ื•ืฉืื™ื ืขื ื”ืขืจื•ืช ืงื•ืœื™ื•ืช ื•ื˜ืงืกื˜
ื–ื”ื• ืฉื“ื” ื—ื•ื‘ื”.
ืขื“ื›ื•ืŸ ืื—ืจื•ืŸ ื‘ืชืืจื™ืš
1 ื‘ื™ื•ืœื™ 2024

ืื‘ื˜ื—ืช ื ืชื•ื ื™ื

ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ื”ื‘ื˜ื™ื—ื•ืช ืฆืจื™ืš ืงื•ื“ื ื›ืœ ืœื”ื‘ื™ืŸ ืื™ืš ื”ืžืคืชื—ื™ื ืื•ืกืคื™ื ื•ืžืฉืชืคื™ื ืืช ื”ื ืชื•ื ื™ื ืฉืœืš. ื ื•ื”ืœื™ ืคืจื˜ื™ื•ืช ื”ื ืชื•ื ื™ื ื•ืื‘ื˜ื—ืช ื”ื ืชื•ื ื™ื ืขืฉื•ื™ื™ื ืœื”ืฉืชื ื•ืช ื‘ื”ืชืื ืœืฉื™ืžื•ืฉ, ืœืื–ื•ืจ ื•ืœื’ื™ืœ ื”ืžืฉืชืžืฉ. ื”ืžืคืชื— ืกื™ืคืง ืืช ื”ืžื™ื“ืข ื”ื–ื” ื•ื”ื•ื ืขืฉื•ื™ ืœืขื“ื›ืŸ ืื•ืชื• ืžื“ื™ ืคืขื.
ืœื ืžืชื‘ืฆืข ืฉื™ืชื•ืฃ ื ืชื•ื ื™ื ืขื ืฆื“ื“ื™ื ืฉืœื™ืฉื™ื™ื
ื”ืืคืœื™ืงืฆื™ื” ื”ื–ืืช ืขืฉื•ื™ื” ืœืืกื•ืฃ ืืช ืกื•ื’ื™ ื”ื ืชื•ื ื™ื ื”ืืœื”
ืคืจื˜ื™ื ืื™ืฉื™ื™ื
ื”ื ืชื•ื ื™ื ืœื ืžื•ืฆืคื ื™ื
ื‘ืืคืฉืจื•ืชืš ืœื‘ืงืฉ ืฉื ืชื•ื ื™ื ื™ื™ืžื—ืงื•

ื“ื™ืจื•ื’ื™ื ื•ื‘ื™ืงื•ืจื•ืช

3.2
33 ื‘ื™ืงื•ืจื•ืช

ืžื” ื—ื“ืฉ

Android 14 support.
Bug fixes.

ืชืžื™ื›ื” ื‘ืืคืœื™ืงืฆื™ื”

ืžืกืคืจ ื˜ืœืคื•ืŸ
+15082993000
ืžื™ื“ืข ืขืœ ืžืคืชื—ื™ ื”ืืคืœื™ืงืฆื™ื”
Skyscape Medpresso, Inc.
support@skyscape.com
11 Apex Dr Ste 300A Marlborough, MA 01752 United States
+1 978-828-0499

โ€ซืขื•ื“ ืžื‘ื™ืช Skyscape Medpresso Incโ€Žโ€